Cover Image

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis

Data concerning the economic and humanistic burden in patients with paediatric atopic dermatitis (AD) and their families are scarce. This retrospective study investigated these burdens in paediatric patients with AD using maintenance treatment with topical corticosteroids and/or conventional systemi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Roselie Achten (Author), Lisa van der Rijst (Author), Marjanne Piena (Author), Hedda Lamers (Author), Fleur de Beer (Author), Marjolein de Bruin-Weller (Author), Marlies de Graaf (Author)
Format:	Book
Published:	Medical Journals Sweden, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
by: Roselie E. Achten, et al.
Published: (2022)

Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps
by: Lisa P. van der Rijst, et al.
Published: (2023)

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment
by: Lieneke F.M. Ariëns, et al.
Published: (2019)

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry
by: Celeste M. Boesjes, et al.
Published: (2023)

Nomenclature and clinical phenotypes of atopic dermatitis
by: Giampiero Girolomoni, et al.
Published: (2021)

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs
by: Floor M. Garritsen, et al.
Published: (2017)

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
by: Esmé Kamphuis, et al.
Published: (2024)

Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey
by: Matthias Augustin, et al.
Published: (2022)

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib
by: Shawn G. Kwatra, et al.
Published: (2024)

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry
by: Celeste M. Boesjes, et al.
Published: (2022)

Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids
by: Lieneke F.M. Ariëns, et al.
Published: (2018)

The Treat-to-Target Project in Atopic Dermatitis: One Year On
by: Marjolein de Bruin-Weller, et al.
Published: (2023)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022)

Effect of Paediatric Atopic Dermatitis on Parental Sleep Quality
by: Ester Forer, et al.
Published: (2023)

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial
by: Jonathan Weyne, et al.
Published: (2020)

Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
by: Jonathan I. Silverberg, et al.
Published: (2021)

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
by: Melinda J. Gooderham, et al.
Published: (2024)

Factors Influencing Family Burden of Paediatric Patients with Atopic Dermatitis: A Cross-sectional Study
by: Xiaomeng Xu, et al.
Published: (2020)

Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis
by: Eric L. Simpson, et al.
Published: (2019)

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry
by: Lieneke F.M. Ariëns, et al.
Published: (2021)

More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis
by: Andrew Blauvelt, et al.
Published: (2024)

Patch Testing in Toilet Seat Dermatitis: A Case Series of Six Patients with Paediatric Atopic Dermatitis
by: Farheen Begum, et al.
Published: (2024)

Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies
by: Marjolein De Bruin-Weller, et al.
Published: (2021)

No Association Between First Exposure to General Anaesthesia and Atopic Dermatitis in the Paediatric Population
by: Dong Chan Kim, et al.
Published: (2022)

Botanical Extract Coacillium for Management of Paediatric Atopic Dermatitis: A Case Report
by: Philipp Spring
Published: (2023)

Economic Burden of Atopic Dermatitis in Taiwan
by: Ellen M. Lee, et al.
Published: (2023)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
by: Mette Deleuran, et al.
Published: (2021)

Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis
by: Tan SP, et al.
Published: (2017)

Societal economic burden and determinants of costs for atopic dermatitis
by: Gustaf Ortsäter, et al.
Published: (2022)

Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London
by: Anjali Rampersad, et al.
Published: (2024)

Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process
by: Jacob P. Thyssen, et al.
Published: (2020)

Current burden of atopic dermatitis in India: A systematic literature review
by: Abhishek De, et al.
Published: (2023)

Intrinsic Atopic Dermatitis and Extrinsic Atopic Dermatitis: Similarities and Differences
by: Liu L, et al.
Published: (2022)

ATOPIC DERMATITIS
by: L.S. Namazova, et al.
Published: (2006)

ATOPIC DERMATITIS
by: L.S. Namazova, et al.
Published: (2006)

Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
by: Lieneke F.M. Ariëns, et al.
Published: (2019)

Understanding the Burden of Atopic Dermatitis in Africa and the Middle East
by: Khalid Abdullah Mohammad Al-Afif, et al.
Published: (2019)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
by: Neide Kalil Gaspar, et al.
Published: (2016)

Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
by: Thomas Bieber, et al.
Published: (2023)

A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis
by: F. Wilson, et al.
Published: (2021)